cancer clinical trials for Lymphoma/CLL (ONC)

18 Lymphoma/CLL (ONC) clinical trials found. View a list of all cancer clinical trial types.

• EA4151, A Randomized Phase III Trial of Consolidation with Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs. Maintenance Rituximab Alone for Patients with Mantle Cell Lymphoma In Minimal Residual Disease-Negative First Complete Remission

  Current Status: Open

  View links and contact information related to this clinical trial

• Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• Managed Access Program (MAP) Cohort Treatment Plan CCTL019B2003I to provide access for patients with out of specification leukapheresis product and/or out of specification manufactured tisagenlecleucel (CTL019; Kymriah®)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase 1B/3 Double-Blind, Randomized, Active-Controlled, 3-Stage, Biomarker Adaptive Study of Tazemetostat or Placebo in Combination with Lenalidomide Plus Rituximab in Subjects with Relapsed/Refractory Follicular Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• An open-label phase II study to investigate the efficacy, safety, and pharmacokinetics of tirabrutinib in patients with Primary Central Nervous System Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase 1 study evaluating SC291, a hypoimmune allogeneic CD19-directed CAR T cell therapy, in relapsed and/or refractory B-cell malignancies

  Current Status: Open

  View links and contact information related to this clinical trial

• A Randomized Phase II Study of CHO(E)P vs CC-486-CHO(E)P vs Duvelisib-CHO(E)P in Previously Untreated CD30 Negative Peripheral T-Cell Lymphomas

  Current Status: Open

  View links and contact information related to this clinical trial

• FT522-101: A Phase 1 Study of FT522 in Combination with Rituximab in Participants with Relapsed/Refractory BCell Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Axicabtagene Ciloleucel

  Current Status: Open

  View links and contact information related to this clinical trial

• Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Brexucabtagene Autoleucel

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase 1b, Open Label, Global, Multicenter, Dose Determination, Randomized Dose Expansion Study to Determine the Maximum Tolerated Dose, Assess the Safety and Tolerability, Pharmacokinetics and Preliminary Efficacy of Iberdomide (CC-220) in Combination With R-CHOP-21 and CC-99282 in Combination With R-CHOP-21 for Subjects With Previously Untreated Aggressive B-cell Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• Expanded Access Protocol (EAP) For Patients Receiving Lisocabtagene Maraleucel That Is Nonconforming For Commercial Release

  Current Status: Open

  View links and contact information related to this clinical trial

• Targeted Agent and Profiling Utilization Registry (TAPUR) Study

  Current Status: Open

  View links and contact information related to this clinical trial

• Long-term Follow-up Protocol For Subjects Treated with Gene-modified T Cells

  Current Status: Open

  View links and contact information related to this clinical trial

• An Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• A Randomized Phase 3 Trial of Continuous vs. Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older Patients with Mantle Cell Lymphoma (INTERCON)

  Current Status: Open

  View links and contact information related to this clinical trial

• Low Dose Radiation as Bridging Therapy for Lisocabtagene Maraleucel in Relapsed B-Cell Non-Hodgkin Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• A Pilot, Randomized, Double-blind, Placebo-controlled Study using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation in Multiple Myeloma and Lymphoma: The PRIMAL Trial

  Current Status: Open

  View links and contact information related to this clinical trial